Krt5-CreERT2 knock-in mice have both endogenous gene and tamoxifen-inducible Cre recombinase expression directed to basal epithelial cells by the endogenous promoter/enhancer elements of the keratin 5 locus. These mice may be useful in generating conditional alleles for studying basal cells, cancer and epidermolysis bullosa.
Brigid LM Hogan, Duke University Medical Center
Genetic Background | Generation |
---|---|
?+pN2F5
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Recombinase-expressing, Inducible) | Krt5 | keratin 5 |
Starting at:
$255.00 Domestic price for female 4-week |
333.51 Domestic price for breeder pair |
The keratin 5 gene (Krt5) encodes cytokeratin-5 or K5, a type II cytokeratin specifically expressed in basal epithelial cells (including epidermis, salivary gland and digestive tract). K5 is a biomarker for several different types of cancer (including breast and lung).
The Krt5-CreERT2 knock-in allele has an IRES sequence and a tamoxifen-inducible Cre recombinase (CreERT2) inserted in the 3' UTR of Krt5. As such, Krt5-CreERT2 mice have both endogenous gene and CreERT2 expression directed to basal epithelial cells by the endogenous promoter/enhancer elements of the keratin 5 locus. CreERT2 fusion gene activity is inducible; observed following tamoxifen administration. When Krt5-CreERT2 mice are bred with mice containing loxP-flanked sequences, tamoxifen-inducible Cre-mediated recombination will result in deletion of floxed sequences in the Krt5-expressing cells of the double mutant offspring.
Specifically, tamoxifen-inducible Cre recombinase activity recapitulates the endogenous Krt5 expression pattern. Recombination efficiency is reported to be high in the basal layer of the epidermis, prostate and esophagus, but only 25% in the basal cells of the trachea (which may reflect the lower Krt5 expression in this tissue). The donating investigator did not characterize if Cre recombinase is expressed prior to tamoxifen exposure. Heterozygotes are viable and fertile with no reported abnormalities. To date (May 2016), it has not been attempted to make this strain homozygous.
For example, when Krt5-CreERT2 mice are bred to have a cre-conditional knockout of suppressor of cytokine signals 3 (Socs3flox; Stock No. 010944) and fluorescent cre-reporter (R26-LSL-EYFP; Stock No. 006148), the resulting triple mutant mice allow tamoxifen-inducible deletion of Socs3 in basal cells and activation of YFP expression as a lineage tracer. Such animals are useful for studying negative feedback regulation / inhibition of the JAK/STAT3 pathway.
The Cre-ERT2 fusion protein consists of Cre recombinase fused to a triple mutant form of the human estrogen receptor which does not bind its natural ligand (17β-estradiol) at physiological concentrations but will bind the synthetic estrogen receptor ligands 4-hydroxytamoxifen (OHT or tamoxifen) and, with lesser sensitivity, ICI 182780. Restricted to the cytoplasm, Cre-ERT2 can only gain access to the nuclear compartment after exposure to tamoxifen. To counteract the mixed estrogen agonist effects of tamoxifen injections, which can result in late fetal abortions in pregnant mice, progesterone may be coadministered.
The Krt5-CreERT2 knock-in allele (K5-CreER, K5-CreERT2 or K5CREER) was created by the laboratory of Dr. Brigid LM Hogan (Duke University Medical Center) to have an IRES-CreERT2 inserted into the 3' UTR of the keratin 5 gene (Krt5) on chromosome 15. The specific details are below.
The targeting vector contained, from 5' to 3', an internal ribosome entry site (IRES), a CreERT2 fusion gene (Cre-ERT2; Cre recombinase fused to a G400V/M543A/L544A triple mutation of the human estrogen receptor ligand binding domain) and an frt-flanked neomycin selection cassette. This construct was electroporated into 129S6/SvEvTac-derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into recipient blastocysts and chimeric males were bred with B6;SJL-Tg(ACTFLPe)9205Dym/J females (Stock No. 003800) to remove the neo selection cassette. The resulting Krt5-CreERT2 colony was maintained by breeding to C57BL/6NCrl wildtype mice for at least eight generations (and the FLPe transgene was removed) prior to sending male mice to The Jackson Laboratory Repository in 2016. Upon arrival, sperm was cryopreserved. To establish our live colony, an aliquot of frozen sperm was used to fertilize C57BL/6N oocytes (Stock No. 005304).
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
---|---|
Site of Expression | Tamoxifen-inducible Cre recombinase is expressed in basal epithelial cells. |
Allele Name | targeted mutation 1.1, Brigid L Hogan |
---|---|
Allele Type | Targeted (Recombinase-expressing, Inducible) |
Allele Synonym(s) | K5-CreERT2; Krt5tm1.1Blh |
Gene Symbol and Name | Krt5, keratin 5 |
Gene Synonym(s) | |
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
Site of Expression | Tamoxifen-inducible Cre recombinase is expressed in basal epithelial cells. |
Strain of Origin | 129S6/SvEvTac |
Chromosome | 15 |
Molecular Note | An IRES-cre/ERT2 fragment was inserted into the 3'UTR of the Krt5 gene along with an FRT flanked neomycin selection cassette. The selection cassette was subsequenty excised from properly targeted mice using flp recombinase. |
When maintaining a live colony, heterozygous mice may be bred together, to wildtype mice from the colony or to C57BL/6NJ inbred mice (Stock No. 005304). To date (May 2016), it has not been attempted to make this strain homozygous.
When using the K5-CreERT2 knock-in mouse strain in a publication, please cite the originating article(s) and include JAX stock #029155 in your Materials and Methods section.
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Krt5<tm1.1(cre/ERT2)Blh> |
Frozen Mouse Embryo | B6N.129S6(Cg)-Krt5<tm1.1(cre/ERT2)Blh>/J | $2595.00 |
Frozen Mouse Embryo | B6N.129S6(Cg)-Krt5<tm1.1(cre/ERT2)Blh>/J | $2595.00 |
Frozen Mouse Embryo | B6N.129S6(Cg)-Krt5<tm1.1(cre/ERT2)Blh>/J | $3373.50 |
Frozen Mouse Embryo | B6N.129S6(Cg)-Krt5<tm1.1(cre/ERT2)Blh>/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.